Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:625180.
doi: 10.1155/2014/625180. Epub 2014 Jul 16.

Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome

Affiliations

Endocan levels in peripheral blood predict outcomes of acute respiratory distress syndrome

Ling Tang et al. Mediators Inflamm. 2014.

Abstract

Purpose: To investigate the prognostic significance of endocan, compared with procalcitonin (PCT), C-reactive protein (CRP),white blood cells (WBC), neutrophils (N), and clinical severity scores in patients with ARDS.

Methods: A total of 42 patients with ARDS were initially enrolled, and there were 20 nonsurvivors and 22 survivors based on hospital mortality. Plasma levels of biomarkers were measured and the acute physiology and chronic health evaluation II (APACHE II) was calculated on day 1 after the patient met the defining criteria of ARDS.

Results: Endocan levels significantly correlated with the APACHE II score in the ARDS group (r = 0.676, P = 0.000, n = 42). Of 42 individuals with ARDS, 20 were dead, and endocan was significantly higher in nonsurvivors than in survivors (median (IQR) 5.01 (2.98-8.44) versus 3.01 (2.36-4.36) ng/mL, P = 0.017). According to the results of the ROC-curve analysis and COX proportional hazards models, endocan can predict mortality of ARDS independently with a hazard ratio of 1.374 (95% CI, 1.150-1.641) and an area of receiver operator characteristic curve (AUROC) of 0.715 (P = 0.017). Moreover, endocan can predict the multiple-organ dysfunction of ARDS.

Conclusion: Endocan is a promising biomarker to predict the disease severity and mortality in patients with ARDS.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlations of plasma endocan with procalcitonin (PCT), C-reactive protein (CRP), white blood cells (WBC), and APACHE II in 42 patients with acute respiratory distress syndrome (Spearman rank analysis). r represents Spearman's correlation coefficients, and P value less than 0.05 was considered statistically significant.
Figure 2
Figure 2
Motality prediction by plasma levels of endocan, PCT, CRP, WBC and Neutrophil counts and APACHE II scores in patients with acute respiratory distress syndrome using the receiver operating characteristic (ROC) curves.The optimal cutoff points for each plasma biomarker level and severity score were listed in the attached table, P value less than 0.05 was considered statistically significant.

References

    1. Phua J, Badia JR, Adhikari NKJ, et al. Has mortality from acute respiratory distress syndrome decreased over time? American Journal of Respiratory and Critical Care Medicine. 2009;179(3):220–227. - PubMed
    1. Rubenfeld GD, Herridge MS. Epidemiology and outcomes of acute lung injury. Chest. 2007;131(2):554–562. - PubMed
    1. Herridge MS, Tansey CM, Matté A, et al. Functional disability 5 years after acute respiratory distress syndrome. The New England Journal of Medicine. 2011;364(14):1293–1304. - PubMed
    1. Stüber F, Wrigge H, Schroeder S, et al. Kinetic and reversibility of mechanical ventilation-associated pulmonary and systemic inflammatory response in patients with acute lung injury. Intensive Care Medicine. 2002;28(7):834–841. - PubMed
    1. Ware LB, Koyama T, Billheimer DD, et al. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest. 2010;137(2):288–296. - PMC - PubMed

Publication types